Chemours Company
CC
Market Cap$1.87B
Close$
$-4.02
136.4% downside
Current Fair Value
136.4% downsideOvervalued by 136.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.87 Billion |
|---|---|
| Enterprise Value | $5.50 Billion |
| Dividend Yield | $1 (8%) |
| Earnings per Share | $0.58 |
| Beta | 1.82 |
| Outstanding Shares | 149,825,988 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 21.53 |
|---|---|
| PEG | -9.16 |
| Price to Sales | 0.29 |
| Price to Book Ratio | 2.77 |
| Enterprise Value to Revenue | 0.96 |
| Enterprise Value to EBIT | 17.98 |
| Enterprise Value to Net Income | 79 |
| Total Debt to Enterprise | 0.79 |
| Debt to Equity | 7.2 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Chemours Company
7,000 employees
CEO: Mark Vergnano The Chemours Company is a global leader in Titanium Technologies, Fluoroproducts, and Chemical Solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemi...